A detailed history of Gamma Investing LLC transactions in Glaukos Corp stock. As of the latest transaction made, Gamma Investing LLC holds 133,064 shares of GKOS stock, worth $13.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
133,064
Previous 2,213 5912.83%
Holding current value
$13.6 Million
Previous $332 Million 99.59%
% of portfolio
0.01%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 07, 2025

BUY
$96.6 - $161.22 $12.6 Million - $21.1 Million
130,851 Added 5912.83%
133,064 $1.35 Million
Q4 2024

Jan 02, 2025

BUY
$126.42 - $152.67 $61,692 - $74,502
488 Added 28.29%
2,213 $332 Million
Q3 2024

Oct 04, 2024

BUY
$113.62 - $135.39 $60,559 - $72,162
533 Added 44.71%
1,725 $225 Million
Q2 2024

Jul 02, 2024

BUY
$89.48 - $118.35 $43,487 - $57,518
486 Added 68.84%
1,192 $141 Million
Q1 2024

Apr 05, 2024

BUY
$76.4 - $96.33 $687 - $866
9 Added 1.29%
706 $66.6 Million
Q4 2023

Feb 01, 2024

BUY
$59.53 - $85.11 $41,492 - $59,321
697 New
697 $62.1 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.85B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.